Articles
IDT to acquire 23 more generic drugs
IDT Australia (ASX:IDT) has entered a conditional deal to acquire 23 previously marketed generic drugs for conditions including Parkinson's, depression and pain. [ + ]
2014 Prime Minister's Prizes for Science
The winners of the 2014 Prime Minister's Prizes for Science were announced this week at a black-tie dinner held at Parliament House. [ + ]
Laser system for ANFF's South Australian node
A laser system from Kloe has been installed at the South Australian node of the Australian National Fabrication Facility (ANFF). ANFF-SA identified that a high-quality rapid prototyping/lithography system was required to meet its business commitments. [ + ]
Clinical Genomics signs China partner for FIT
Clinical Genomics has appointed BioChain Group as the exclusive Chinese distributor for its faecal immunochemical colorectal cancer screening test. [ + ]
Johnson & Johnson Innovation Industry Excellence Awards recognise biotechnology leaders at AusBiotech 2014
Medtech featured strongly when the prestigious Johnson & Johnson Innovation Industry Excellence Awards 2014 were announced, recognising those at the forefront of Australia's world-class biotech, medical technology and healthcare sectors in Australia. [ + ]
GM crops: new directions
Australia's GM crop revolution has stalled, after an auspicious debut in 1989 when South Australia became the first state in the world to release a genetically modified organism into the environment. [ + ]
Alchemia shares sink on negative trial result
Alchemia (ASX:ACL) has revealed that its phase III trial of HA-Irinotecan in metastatic colorectal cancer failed to meet the primary end point of an improvement of PFS against the control group. [ + ]
CSL to buy Novartis's flu vaccine business
CSL (ASX:CSL) will pay around $310m to acquire Novartis's flu vaccine business and merge it with bioCSL - in a deal expected to create the second largest player in the global market. [ + ]
Clinuvel's Scenesse gets EMA nod in EPP
The European Medicines Agency has voted to grant marketing authorisation to Clinuvel's Scenesse in rare and severe skin disorder erythropoietic protoporphyria. [ + ]
Ancient roots of the mammalian immune response
An unsuspected link between the mammalian immune system and the communication systems of simpler organisms such as bacteria has been uncovered.
[ + ]Novogen's Trilexium shows promise in child cancers
Novogen (ASX:NRT) said lab studies of drug candidate Trilexium show its potential in treating paediatric diffuse pontine glioma and paediatric neuroblastoma cells. [ + ]
The business of collaboration
Having developed an expertise in the social side of science, the CEO of the Cooperative Research Centre Association, Professor Tony Peacock, is putting his skills to the test in building collaborations between researchers, industry and the community. [ + ]
All chemists are invited to the RACI National Congress
The Royal Australian Chemical Institute National Congress, to be held in Adelaide from 7-12 December, will be the largest gathering of Australian chemists since 2005 and everyone is welcome. Over 100 plenary, keynote and invited speakers have been drawn from around the world and represent some of the most important work in the chemical community.
[ + ]PM opens Westmead medical research centre
The Westmead Millennium Institute for Medical Research (WMI) has been opened by Prime Minister Tony Abbott and NSW Premier Mike Baird, bringing together several centres of research which were previously spread across six locations on the Westmead hospital campus. [ + ]
Sirtex completes SIRFLOX trial
Sirtex Medical (ASX:SRT) has completed its SIRFLOX trial of its SIR-Spheres in inoperable liver cancer and is making progress recruiting patients in three other trials. [ + ]